Value in Health Regional Issues, published by Elsevier, is an essential academic journal that addresses critical developments in the field of health economics, policy, and pharmaceuticals. With an impressive impact factor, this journal has established itself as a leading platform for disseminating innovative research, evidenced by its Q1 quartile ranking in Economics, Econometrics and Finance and Pharmacology, Toxicology and Pharmaceutics. Founded in 2012, the journal is dedicated to exploring value-based healthcare, focusing on regional perspectives that highlight economic implications and health outcomes. Covering a convergence of multidisciplinary themes, the journal fosters academic collaboration and provides researchers, professionals, and students with access to high-quality, peer-reviewed articles. As it continues to expand its scope through 2025, Value in Health Regional Issues remains a pivotal resource for those seeking to understand and influence health policy and economic frameworks on a regional, national, and global scale.

Health Policy OPEN is an esteemed open-access journal published by Elsevier that has made significant contributions to the field of health policy since its inception in 2020. With an impact factor placing it in the prestigious Q2 category of health policy journals, it ranks 116 out of 310 within the Scopus database, highlighting its critical engagement in the field and situating it within the 62nd percentile. As an open-access platform, Health Policy OPEN promotes the dissemination of high-quality research, making it accessible to a global audience of researchers, professionals, and students alike. The journal focuses on topical issues, innovative approaches, and evidence-based practices that shape health policies worldwide. With its headquarters in Amsterdam, Netherlands, the journal serves as a vital resource for advancing knowledge and fostering discussions that drive health policy initiatives and reforms. Engage with Health Policy OPEN to contribute to the evolving landscape of health policy and to stay informed on the latest research advancements.

Health Policy and Technology is a prestigious academic journal published by ELSEVIER SCI LTD that has established itself as a leader in the fields of Biomedical Engineering and Health Policy. With an impressive Q1 ranking in both disciplines as of 2023, the journal offers a platform for original research, reviews, and innovative technological solutions that aim to bridge the gap between health policy and technology. Since its inception in 2012, it has served as a vital resource for researchers, professionals, and students who are seeking to explore the impact of technology on healthcare systems and policies globally. Although it is not an open-access journal, the high-quality, peer-reviewed articles published within its pages contribute significantly to the discourse on the advancement of healthcare practices. The journal's commitment to disseminating groundbreaking studies ensures it remains a crucial reference point in these rapidly evolving fields.

ADVANCES IN THERAPY is a prestigious peer-reviewed journal published by SPRINGER, specializing in the diverse fields of medicine and pharmacology. Established in 1984, this influential journal has become an essential resource for researchers and professionals, boasting a commendable impact factor and categorically ranking within the Q1 quartile in both Medicine (Miscellaneous) and Medical Pharmacology as of 2023. With an impressive Scopus ranking at #52 out of 272 in the realm of medical pharmacology, it places itself in the top 81st percentile, underscoring its importance in advancing therapeutic knowledge and practices. Although the journal is not open access, it provides invaluable insights and the latest research findings in therapies that significantly impact patient care, making it a vital reference for clinicians, academicians, and students alike.

Cost Effectiveness and Resource Allocation is a premier open-access journal published by BMC, dedicated to advancing the field of health policy and economics. Since its inception in 2003, the journal has provided a platform for researchers, policymakers, and healthcare professionals to disseminate crucial findings and insights relevant to cost-effectiveness analyses and resource allocation strategies. With an increasing impact factor and ranking within the Q2 category of health policy journals, it ranks #138 out of 310 in Scopus, placing it in the 55th percentile among its peers. The journal aims to facilitate knowledge exchange that can transform health policy and improve healthcare delivery through rigorous research, evaluation, and dialogue. Open access since its establishment, it ensures that critical findings are available to a global audience, thereby enhancing the impact and reach of its published works.

Risk Management and Healthcare Policy is an esteemed Open Access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the fields of health policy and public health. Established in 2008, the journal fosters a rich dialogue among researchers, professionals, and students, focusing on innovative strategies for managing risks within healthcare systems. With a current impact factor reflected in its robust Scopus rankings—placing it in the top quartile (Q2) in both Health Policy and Public Health, Environmental and Occupational Health—the journal is a pivotal resource that shares critical insights and evidence-based practices. The journal not only covers empirical studies and analytical research but also promotes discussions on emerging challenges and opportunities within the healthcare sector. As a result, Risk Management and Healthcare Policy serves as a vital platform for disseminating high-quality research, fostering collaboration, and informing policy decisions aimed at enhancing health outcomes globally.

JAMA Internal Medicine is a premier scholarly journal published by the American Medical Association, renowned for its rigorous peer-review process and commitment to advancing the field of internal medicine. With an impressive impact factor that positions it in the upper echelon of medical journals, specifically ranked at Q1 in Internal Medicine and holding a remarkable Scopus rank of #2 out of 167, the journal provides a vital platform for original research, reviews, and enlightening discussions that shape clinical practices and policies. As an accessible repository of cutting-edge findings and comprehensive analyses, JAMA Internal Medicine offers both subscription and open access options, ensuring that the latest developments in medicine are available to clinicians, researchers, and the academic community at large. With its focus spanning from 2013 to 2024 and its dedication to high-quality scholarship, the journal serves as an essential resource for those seeking to enhance their understanding of the complexities of internal medicine and improve patient care.

VALUE IN HEALTH, published by Elsevier Science Inc, is a premier peer-reviewed journal in the fields of Health Policy, Medicine, and Public Health. With an impressive impact factor reflecting its respected standing, the journal has achieved a distinguished Q1 classification in multiple categories, placing it among the top publications in the health domain. Since its inception in 1998, this journal has been a vital platform for disseminating research that informs health policy and practice, impacting both clinical and public health decision-making. The journal’s Scopus rankings further underscore its global influence, with notable positions in Medicine and Public Health sectors. VALUE IN HEALTH is committed to fostering an environment where innovative research meets practical application, ultimately aiming to enhance health outcomes worldwide. Researchers, professionals, and students alike are encouraged to explore the wealth of knowledge contained within its pages.

Pilot and Feasibility Studies, published by BMC, stands at the forefront of innovative research in the realm of pilot studies and feasibility assessments, serving as a vital resource for researchers in medicine and healthcare. As an Open Access journal since 2015, it provides unrestricted access to its content, promoting the dissemination of significant findings and fostering collaboration among the global research community. Based in the United Kingdom, this journal has solidly established its reputation, ranking in the Q2 quartile for medicine (miscellaneous) in 2023 with a Scopus rank of #183 out of 398, placing it within the 54th percentile. The journal's scope encompasses a wide range of methodologies and applications, encouraging the translation of pilot studies into viable healthcare practices. With a commitment to quality and accessibility, Pilot and Feasibility Studies plays an essential role in enhancing the rigor and impact of preliminary research, ultimately contributing to the advancement of medical science.

Applied Health Economics and Health Policy, published by Springer International Publishing AG, stands as a premier academic journal dedicated to the intersection of economic theory and health policy. With a strong focus on the practical application of economic principles to health issues, this journal addresses crucial topics such as healthcare financing, resource allocation, and economic evaluation of health interventions. Its impressive rankings—in the top quartile for both Health Policy and Medicine, as well as a notable second quartile in Economics—illustrate its significant impact within the fields of health economics and policy research. The journal is aimed at researchers, policymakers, and students who seek to explore innovative solutions to contemporary health challenges. Established in 2002 with ongoing publications through 2024, the journal features open access options that enhance accessibility and engagement with its extensive body of research articles, ensuring that vital insights are available to a global audience.